Propanc Biopharma Inc. (PPCB)
NASDAQ · Healthcare
Propanc Biopharma Inc. Long Term Debt 2020–2025
Propanc Biopharma Inc. annual long term debt history from 2022 to 2025. Long term debt refers to financial obligations that are due more than one year in the future.
- Propanc Biopharma Inc. long term debt as of June 30, 2025: 147,376, a 151.31% increase year-over-year.
- Propanc Biopharma Inc. long term debt for 2025 were 147,376, a 151.31% increase from 2024.
- Propanc Biopharma Inc. long term debt for 2024 were 58,642, a 204.19% increase from 2023.
- Propanc Biopharma Inc. long term debt for 2023 were 19,278, a 54.45% decrease from 2022.
- Propanc Biopharma Inc. long term debt for 2022 were 42,319.
Long Term Debt
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Propanc Biopharma Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2025 | $0 |
| 2024 | $0 |
| 2023 | $0 |
| 2022 | $0 |
Propanc Biopharma Inc. Long Term Debt — FAQ
Propanc Biopharma Inc. (PPCB) long term debt over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see PPCB's long term debt history?
The chart and table above show Propanc Biopharma Inc.'s long term debt by year and by quarter, including the growth rate.